New drug shows promise against tough cancers in first chinese trial
NCT ID NCT05460273
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called Dato-DXd in Chinese patients with advanced non-small-cell lung cancer or triple-negative breast cancer that has spread or stopped responding to treatment. The drug targets and kills cancer cells by attaching to them and blocking growth. About 119 participants will receive the drug every 3 weeks until their cancer worsens. The goal is to see how well it shrinks tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Beijing, 100039, China
-
Research Site
Beijing, 100044, China
-
Research Site
Beijing, 100142, China
-
Research Site
Bengbu, 233004, China
-
Research Site
Changchun, 130012, China
-
Research Site
Changchun, 130021, China
-
Research Site
Chengdu, 610000, China
-
Research Site
Chongqing, 400030, China
-
Research Site
Dalian, 116023, China
-
Research Site
Fuzhou, 350001, China
-
Research Site
Guangzhou, 510060, China
-
Research Site
Guangzhou, 510100, China
-
Research Site
Hangzhou, 310022, China
-
Research Site
Harbin, 150081, China
-
Research Site
Jinan, 250030, China
-
Research Site
Jinan, 250117, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Nanchang, 330009, China
-
Research Site
Shenyang, 110042, China
-
Research Site
Wuhan, 430022, China
-
Research Site
Wuhan, 430030, China